CATTANEO, STEFANO
CATTANEO, STEFANO
Facoltà di Medicina e Chirurgia
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus
2025-01-01 Terzic, B.; Melin, E.; Fagergren, P.; Dobry, D.; Cattaneo, S.; Giupponi, I.; Bettegazzi, B.; Simonato, M.; Agerman, K.; Kokaia, M.; Moon, L.; Ramsburg, E.
Cell-attached and whole-cell patch-clamp recordings of dopamine neurons in the substantia Nigra pars compacta of mouse brain slices
2021-01-01 Cattaneo, S.; Regoni, M.; Sassone, J.; Taverna, S.
Combinatorial gene therapy for epilepsy
2022-04-07 Cattaneo, Stefano
Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential
2025-01-01 Porcari, Cristina; Cattaneo, Stefano; Crippa, Lucia; Simonato, Michele; Bettegazzi, Barbara
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells
2024-01-01 Cattaneo, S.; Bettegazzi, B.; Crippa, L.; Asth, L.; Regoni, M.; Soukupova, M.; Zucchini, S.; Cantore, A.; Codazzi, F.; Valtorta, F.; Simonato, M.
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
2025-01-01 Cattaneo, S.; Bettegazzi, B.; Ingusci, S.; Verlengia, G.; Anna Sofia, T.; Silvia, Z.; Codazzi, F.; Morelli, M. J.; Marzulli, M.; Glorioso, J. C.; Simonato, M.
Gα13 Contributes to LPS-Induced Morphological Alterations and Affects Migration of Microglia
2021-01-01 Bettegazzi, B.; Bellani, S.; Cattaneo, S.; Codazzi, F.; Grohovaz, F.; Zacchetti, D.
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells
2021-01-01 Soukupová, M; Zucchini, S; Trempat, P; Ingusci, S; Perrier-Biollay, C; Barbieri, M; Cattaneo, S; Bettegazzi, B; Falzoni, S; Berthommé, H; Simonato, M.
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays
2024-01-01 Sturaro, C.; Ruzza, C.; Ferrari, F.; Pola, P.; Argentieri, M.; Frezza, A.; Marzola, E.; Bettegazzi, B.; Cattaneo, S.; Pietra, C.; Malfacini, D.; Calo, G.
Neural precursor cells tune striatal connectivity through the release of IGFBPL1
2022-01-01 Butti, Erica; Cattaneo, Stefano; Bacigaluppi, Marco; Cambiaghi, Marco; Scotti, Giulia Maria; Brambilla, Elena; Ruffini, Francesca; Sferruzza, Giacomo; Ripamonti, Maddalena; Simeoni, Fabio; Cacciaguerra, Laura; Zanghì, Aurora; Quattrini, Angelo; Fesce, Riccardo; Panina-Bordignon, Paola; Giannese, Francesca; Cittaro, Davide; Kuhlmann, Tanja; D'Adamo, Patrizia; Rocca, Maria Assunta; Taverna, Stefano; Martino, Gianvito
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity
2020-01-01 Regoni, M.; Cattaneo, S.; Mercatelli, D.; Novello, S.; Passoni, A.; Bagnati, R.; Davoli, E.; Croci, L.; Consalez, G. G.; Albanese, F.; Zanetti, L.; Passafaro, M.; Serratto, G. M.; Di Fonzo, A.; Valtorta, F.; Ciammola, A.; Taverna, S.; Morari, M.; Sassone, J.
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold?
2024-01-01 Bettegazzi, B.; Cattaneo, S.; Simonato, M.; Zucchini, S.; Soukupova, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus | 1-gen-2025 | Terzic, B.; Melin, E.; Fagergren, P.; Dobry, D.; Cattaneo, S.; Giupponi, I.; Bettegazzi, B.; Simonato, M.; Agerman, K.; Kokaia, M.; Moon, L.; Ramsburg, E. | |
| Cell-attached and whole-cell patch-clamp recordings of dopamine neurons in the substantia Nigra pars compacta of mouse brain slices | 1-gen-2021 | Cattaneo, S.; Regoni, M.; Sassone, J.; Taverna, S. | |
| Combinatorial gene therapy for epilepsy | 7-apr-2022 | Cattaneo, Stefano | |
| Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential | 1-gen-2025 | Porcari, Cristina; Cattaneo, Stefano; Crippa, Lucia; Simonato, Michele; Bettegazzi, Barbara | |
| Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells | 1-gen-2024 | Cattaneo, S.; Bettegazzi, B.; Crippa, L.; Asth, L.; Regoni, M.; Soukupova, M.; Zucchini, S.; Cantore, A.; Codazzi, F.; Valtorta, F.; Simonato, M. | |
| Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications | 1-gen-2025 | Cattaneo, S.; Bettegazzi, B.; Ingusci, S.; Verlengia, G.; Anna Sofia, T.; Silvia, Z.; Codazzi, F.; Morelli, M. J.; Marzulli, M.; Glorioso, J. C.; Simonato, M. | |
| Gα13 Contributes to LPS-Induced Morphological Alterations and Affects Migration of Microglia | 1-gen-2021 | Bettegazzi, B.; Bellani, S.; Cattaneo, S.; Codazzi, F.; Grohovaz, F.; Zacchetti, D. | |
| Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells | 1-gen-2021 | Soukupová, M; Zucchini, S; Trempat, P; Ingusci, S; Perrier-Biollay, C; Barbieri, M; Cattaneo, S; Bettegazzi, B; Falzoni, S; Berthommé, H; Simonato, M. | |
| In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays | 1-gen-2024 | Sturaro, C.; Ruzza, C.; Ferrari, F.; Pola, P.; Argentieri, M.; Frezza, A.; Marzola, E.; Bettegazzi, B.; Cattaneo, S.; Pietra, C.; Malfacini, D.; Calo, G. | |
| Neural precursor cells tune striatal connectivity through the release of IGFBPL1 | 1-gen-2022 | Butti, Erica; Cattaneo, Stefano; Bacigaluppi, Marco; Cambiaghi, Marco; Scotti, Giulia Maria; Brambilla, Elena; Ruffini, Francesca; Sferruzza, Giacomo; Ripamonti, Maddalena; Simeoni, Fabio; Cacciaguerra, Laura; Zanghì, Aurora; Quattrini, Angelo; Fesce, Riccardo; Panina-Bordignon, Paola; Giannese, Francesca; Cittaro, Davide; Kuhlmann, Tanja; D'Adamo, Patrizia; Rocca, Maria Assunta; Taverna, Stefano; Martino, Gianvito | |
| Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity | 1-gen-2020 | Regoni, M.; Cattaneo, S.; Mercatelli, D.; Novello, S.; Passoni, A.; Bagnati, R.; Davoli, E.; Croci, L.; Consalez, G. G.; Albanese, F.; Zanetti, L.; Passafaro, M.; Serratto, G. M.; Di Fonzo, A.; Valtorta, F.; Ciammola, A.; Taverna, S.; Morari, M.; Sassone, J. | |
| Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? | 1-gen-2024 | Bettegazzi, B.; Cattaneo, S.; Simonato, M.; Zucchini, S.; Soukupova, M. |